These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2400652)

  • 1. Should women who are known or potential carriers of the Alport gene be accepted as kidney donors?
    Kashtan CE
    Pediatr Nephrol; 1990 May; 4(3):248. PubMed ID: 2400652
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal transplantation from living donor parents in two brothers with Alport syndrome. Can asymptomatic female carriers of the Alport gene be accepted as kidney donors?
    Sessa A; Pietrucci A; Carozzi S; Torri Tarelli L; Tazzari S; Giordano F; Meroni M; Battini G; Valente U; Renieri A
    Nephron; 1995; 70(1):106-9. PubMed ID: 7617088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women with Alport syndrome: risks and rewards of kidney donation.
    Kashtan CE
    Nephrol Dial Transplant; 2009 May; 24(5):1369-70. PubMed ID: 19171688
    [No Abstract]   [Full Text] [Related]  

  • 4. Living related kidney transplantation in a patient with autosomal-recessive Alport syndrome.
    Sakai K; Muramatsu M; Ogiwara H; Kawamura T; Arai K; Aikawa A; Ohara T; Mizuiri S; Joh K; Naito I; Hasegawa A
    Clin Transplant; 2003; 17 Suppl 10():4-8. PubMed ID: 12823249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous adult polycystic kidney disease and Alport syndrome.
    Phelan PJ; Fletcher E; Carroll N; Metcalfe W; Turner AN
    Nephrology (Carlton); 2016 Aug; 21(8):722-3. PubMed ID: 27436620
    [No Abstract]   [Full Text] [Related]  

  • 6. On 'Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations'.
    Voskarides K; Pierides A; Deltas C
    Kidney Int; 2013 Feb; 83(2):331. PubMed ID: 23364590
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal denervation in a patient with Alport syndrome and rejected renal allograft.
    Raju N; Lloyd V; Yalagudri S; Das B; Ravikishore AG
    Indian Heart J; 2015 Dec; 67 Suppl 3(Suppl 3):S71-3. PubMed ID: 26995439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal transplantation in patients with Alport syndrome.
    Kashtan CE
    Pediatr Transplant; 2006 Sep; 10(6):651-7. PubMed ID: 16911486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late presentation of Alport posttransplantation anti-glomerular basement membrane disease.
    de Sandes-Freitas TV; Holanda-Cavalcanti A; Mastroianni-Kirsztajn G; Franco MF; Medina-Pestana JO
    Transplant Proc; 2011 Dec; 43(10):4000-1. PubMed ID: 22172887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kidney allotransplantation from alive related donor in patients with Alport syndrome].
    Goriaĭnov VA; Kaabak MM; Babenko NN; Morozova MM; Aganesov AP; Panin VV; Platova EN; Dymova OV
    Khirurgiia (Mosk); 2016; (1):50-54. PubMed ID: 26977611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The simultaneous appearance of Alport syndrome in a renal transplant donor and the recipient as primary disease recurrence.
    Kürşat S; Erkin E; Kiliçcioglu B
    Nephron; 1998; 79(3):364. PubMed ID: 9678448
    [No Abstract]   [Full Text] [Related]  

  • 12. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
    Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal transplantation in patients with hereditary kidney disease: our experience.
    Mazzarella V; Splendiani G; Tozzo C; Tisone G; Pisani F; Iaria G; Casciani CU
    Contrib Nephrol; 1997; 122():203-6. PubMed ID: 9399068
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease.
    Kelly YP; Patil A; Wallis L; Murray S; Kant S; Kaballo MA; Casserly L; Doyle B; Dorman A; O'Kelly P; Conlon PJ
    Ren Fail; 2017 Nov; 39(1):290-293. PubMed ID: 27917694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.
    Temme J; Peters F; Lange K; Pirson Y; Heidet L; Torra R; Grunfeld JP; Weber M; Licht C; Müller GA; Gross O
    Kidney Int; 2012 Apr; 81(8):779-83. PubMed ID: 22237748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular clues to the nature of disease causing end-stage renal failure.
    Colville D; Dagher H; Miach P; Savige J
    Nephrol Dial Transplant; 2000 Mar; 15(3):429-32. PubMed ID: 10692536
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation in patients with unusual causes of renal failure.
    Wilson RE
    Clin Nephrol; 1976 Feb; 5(2):51-3. PubMed ID: 815067
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose Spinal Block With Continuous Epidural Infusion for Renal Transplantation in a Patient With Alport Syndrome: A Case Report.
    Gobbi F; Sales G; Bretto P; Donadio PP; Brazzi L
    Transplant Proc; 2016 Nov; 48(9):3067-3069. PubMed ID: 27932148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome.
    Gross O; Weber M; Fries JW; Müller GA
    Nephrol Dial Transplant; 2009 May; 24(5):1626-30. PubMed ID: 19028755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.